TRANSGENIC MICE CONTAINING UBIQUITIN ENZYME GENE DISRUPTIONS

Details for Australian Patent Application No. 2002258660 (hide)

Owner DELTAGEN, INC.

Inventors LEVITEN, Michael, W.

Pub. Number AU-A-2002258660

PCT Pub. Number WO2002/079442

Priority 60/280,628 29.03.01 US; 60/301,289 26.06.01 US; 10/108,755 28.03.02 US

Filing date 29 March 2002

Wipo publication date 15 October 2002

Event Publications

3 April 2003 Application Open to Public Inspection

  Published as AU-A-2002258660

19 February 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002258661-TRANSGENIC MICE CONTAINING 5-HT5B SEROTONIN RECEPTOR GENE DISRUPTIONS

2002258659-TRANSGENIC MICE CONTAINING CACNB4 CALCIUM ION CHANNEL GENE DISRUPTIONS